Lazard Asset Management LLC lifted its holdings in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 220.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,969 shares of the technology company’s stock after buying an additional 4,107 shares during the period. Lazard Asset Management LLC’s holdings in Novanta were worth $911,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. KBC Group NV raised its stake in Novanta by 41.6% during the 4th quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock valued at $229,000 after acquiring an additional 441 shares during the last quarter. Exchange Traded Concepts LLC increased its holdings in shares of Novanta by 4.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 120,566 shares of the technology company’s stock valued at $18,419,000 after purchasing an additional 4,648 shares during the period. D. E. Shaw & Co. Inc. purchased a new stake in shares of Novanta during the fourth quarter worth approximately $3,681,000. Proficio Capital Partners LLC acquired a new stake in shares of Novanta during the fourth quarter worth $5,298,000. Finally, Zions Bancorporation N.A. lifted its holdings in shares of Novanta by 21.2% during the fourth quarter. Zions Bancorporation N.A. now owns 14,211 shares of the technology company’s stock worth $2,171,000 after purchasing an additional 2,486 shares during the period. Hedge funds and other institutional investors own 98.35% of the company’s stock.
Novanta Price Performance
Shares of NASDAQ:NOVT opened at $128.31 on Wednesday. Novanta Inc. has a 52 week low of $98.76 and a 52 week high of $187.12. The company has a 50-day moving average price of $122.58 and a 200 day moving average price of $143.84. The company has a market cap of $4.62 billion, a P/E ratio of 76.83 and a beta of 1.51. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61.
Analyst Ratings Changes
Separately, Robert W. Baird cut their price objective on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research report on Monday, March 3rd.
View Our Latest Stock Analysis on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Recommended Stories
- Five stocks we like better than Novanta
- How to Invest in Blue Chip Stocks
- Top 5 Stocks Hedge Funds Are Buying Right Now
- The 3 Best Retail Stocks to Shop for in August
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.